Company / CapEx per Share
Century Therapeutics, Inc. CapEx per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2025
5-year range
$0.00 / $0.77
FY2022-FY2025
Trend
-99.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
CapEx per Share has declined for 3 consecutive years, from $0.77 in FY2022 to $0.00 in FY2025.
Based on SEC 10-K filings.
0.00 in FY2025 with a 3-year CAGR of -86.7%.
Declined from $0.56 to $0.00 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -86.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Century Therapeutics, Inc.'s capex per share has declined for 3 consecutive years.
- In FY2025, capex per share decreased 99.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | -99.2% |
| FY2024 | $0.23 | -59.1% |
| FY2023 | $0.56 | -27.7% |
| FY2022 | $0.77 | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026